These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3747846)

  • 1. Climacteric complaints as influenced by progestogens.
    von Schoultz B
    Maturitas; 1986 Jul; 8(2):107-12. PubMed ID: 3747846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of progestogens in peri- and post-menopausal hormone replacement therapy.
    Postgrad Med J; 1978; 54 Suppl 2():1-100. PubMed ID: 33373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of hormonal therapy in climacteric disorders with special reference to a new method of oral oestrogen treatment (author's transl)].
    Andor J
    Ther Umsch; 1974 Mar; 31(3):182-7. PubMed ID: 4816757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current treatment of climacteric problems].
    Möbius W
    Z Arztl Fortbild (Jena); 1974 Aug; 68(15):796-81. PubMed ID: 4432551
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of a new synthetic estroprogestinic agent in the climacteric and menopause].
    Moggian G; Tamburini E
    Riv Ital Ginecol; 1970; 54(4):265-76. PubMed ID: 4949808
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal therapy in climacteric women: compliance and its socioeconomic impact.
    Notelovitz M
    Public Health Rep; 1989; 104 Suppl(Suppl):70-5. PubMed ID: 2517705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
    Döring GK
    Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone substitution in menopause].
    Keller PJ; Maurer-Major E
    Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of oestrogens and progestogens.
    Lauritzen C
    Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the status of oestrogen replacement therapy.
    Bye PG
    Postgrad Med J; 1978; 54 Suppl 2():7-10. PubMed ID: 368742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old.
    Oldenhave A; Jaszmann LJ; Haspels AA; Everaerd WT
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):772-80. PubMed ID: 8456878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interdisciplinary diagnosis and therapy concepts in climacteric osteoporosis].
    Löttge M; Spieler W; Seifert B; Hemp O
    Zentralbl Gynakol; 1989; 111(12):800-6. PubMed ID: 2475002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen therapy in climacteric].
    Artner J
    Wien Med Wochenschr; 1972 Sep; 122(40):559-62. PubMed ID: 5079727
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):442-8. PubMed ID: 9197447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women.
    Fedor-Freybergh P
    Acta Obstet Gynecol Scand Suppl; 1977; 64():1-91. PubMed ID: 331844
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for replacement of estrogens and progestins in climacteric and in postmenopause. 25. Arbeitstreffen des "Zürcher Gesprächskreises", November 2000].
    Birkhäuser M; Braendle W; Breckwoldt M; Keller PJ; Kuhl H; Runnebaum B
    Gynakol Geburtshilfliche Rundsch; 2001; 41(1):12-5. PubMed ID: 11423732
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogen substitution therapy in climacteric: should progesterone be omitted in hysterectomized women?].
    Huber J
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):257-61. PubMed ID: 1860657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone, progestogens and psychosomatic health of the climacteric woman.
    Bitzer J
    Maturitas; 2009 Apr; 62(4):330-3. PubMed ID: 19091497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.